drugset / Trial / NCT00983554

Metabolic Effects of Steroids in Obese Men

NCT00983554

RandomizedParallel-groupDouble-blindTreatment

Summary

Subjects will be randomized into 4 study groups: 1. Placebo; 2. Anastrazole and Testosterone; 3. Dutasteride and Testosterone; and 4. Testosterone only. A 2 step euglycemic clamp, body composition by dual X-ray absorptiometry scan, hormone and lipid assays will be performed to monitor metabolic effects of each treatment group. We hypothesize that increasing testosterone levels would increase lean mass, decrease fat mass and improve insulin sensitivity. We further hypothesize that improvements in the metabolic profile would decrease with anastrazole and improve with dutasteride, given in conjunction with T administration.

Timeline

Start
2005-06
Primary completion
2009-05
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg
Subject Dutasteride Small molecule 2.5 mg
Subject Testosterone Small molecule 10 g
Background Acyline Protein / enzyme biologic 300 ug/kg Subcutaneous

Indications